Advanced Biomed is trading at $6.33, down 5.94% on September 29, 2026, with no confirmed company-specific catalyst.
- A September 29 news listing reports that Advanced Biomed filed a Form 12b-25 notifying investors of a delayed annual 10-K filing; the report does not establish that the delay caused the decline.
- Major indices were only modestly lower in the supplied market context, so broad-market weakness alone does not explain the move.